Loading…
Dynorphin is a Specific Endogenous Ligand of the κ Opioid Receptor
In the guinea pig ileum myenteric plexus-longitudinal muscle preparation, dynorphin-(1-13) and the prototypical κ agonist ethylketocyclazocine had equally poor sensitivity to naloxone antagonism and showed selective cross protection in receptor inactivation experiments with the alkylating antagonist...
Saved in:
Published in: | Science (American Association for the Advancement of Science) 1982-01, Vol.215 (4531), p.413-415 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In the guinea pig ileum myenteric plexus-longitudinal muscle preparation, dynorphin-(1-13) and the prototypical κ agonist ethylketocyclazocine had equally poor sensitivity to naloxone antagonism and showed selective cross protection in receptor inactivation experiments with the alkylating antagonist β-chlornaltrexamine. In binding assays with membranes from guinea pig brain, ethylketocyclazocine and dynorphin-(1-13) amide were more potent in displacing tritium-labeled ethylketocyclazocine than in displacing typical μ and δ opioid receptor ligands. In the two preparations studied, the dynorphin receptor appears to be the same as the κ opioid receptor. |
---|---|
ISSN: | 0036-8075 1095-9203 |
DOI: | 10.1126/science.6120570 |